GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Quick Heal Technologies Ltd

Quick Heal Technologies: Director Re-appointment Proposal for 5 Years

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 30 Jul 2026, 10:07 PM IST  ·  BSE ID: 300e58cf-7b23-4a4f-8b21-1b0f225380ce
View Original BSE Filing (PDF)
💡
In Simple Terms
The company wants to keep an independent director, Mr. Stiennon, for another five years if shareholders agree.
🤖 AI Summary
  • Board proposes re-appointment of Mr. Richard Stiennon as Independent Director.
  • Second term of 5 consecutive years proposed, commencing September 27, 2026.
  • Nomination and Remuneration Committee recommended the re-appointment.
  • Shareholder approval required at the ensuing Annual General Meeting for confirmation.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Director's Name
Mr. Richard Stiennon
Term of Re-appointment
5 consecutive years
Effective Date of Re-appointment
September 27, 2026
End Date of Re-appointment
September 26, 2031
🏢 How This Affects the Company
⚠️
Risk Impact
The re-appointment signals continuity in the board's oversight and governance structure.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will vote on the re-appointment proposal at the upcoming Annual General Meeting.
👤
Who Is Affected
All shareholders of Quick Heal Technologies Limited are affected as they will have the opportunity to vote on the proposed re-appointment.
🔍
Management Signal
The proposal signals management's intent to maintain experienced independent oversight on the board.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Annual General Meeting date confirmation for shareholder vote.
Minutes of the Annual General Meeting showing voting outcome.
Board composition post-AGM to confirm re-appointment.
LOW RISK This is a routine board governance proposal, subject to standard shareholder approval.
💡 Investor Takeaway
Quick Heal Technologies proposes re-appointing Independent Director Mr. Richard Stiennon for a second 5-year term, subject to shareholder approval at the upcoming AGM.
⚖️ Strengths & Concerns

✅ Positives

  • Proposed 5-year re-appointment term for Mr. Richard Stiennon indicates board stability.
  • Recommendation from Nomination and Remuneration Committee aligns with governance best practices.
❓ Frequently Asked Questions
Who is proposed for re-appointment as an Independent Director at Quick Heal Technologies?
Mr. Richard Stiennon is proposed for re-appointment as a Non-Executive Independent Director.
What is the proposed term for Mr. Richard Stiennon's re-appointment?
The proposed term is for a second term of 5 consecutive years, effective September 27, 2026.
When will Mr. Richard Stiennon's re-appointment be finalized?
The re-appointment is subject to the approval of the shareholders at the ensuing Annual General Meeting.
Who recommended the re-appointment of Mr. Richard Stiennon?
The Nomination and Remuneration Committee of Quick Heal Technologies recommended the re-appointment.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.